Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Tanimoto

Showing results (1-10 of 353) with videos related to

Pageof 36
Sort By:
Drug Design, Development and Therapy|April 8, 2015
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in JapanTetsuya Tanimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2023
Conditioning Regimen in Patients With Adult Acute B Lymphoblastic LeukemiaMotoharu Shibusawa, Tetsuya Tanimoto
JMA Journal|November 23, 2020
Severe Fever with Thrombocytopenia Syndrome: Japan under Threat from Life-threatening Emerging Tick-borne DiseaseAndy Crump, Tetsuya Tanimoto
The Lancet. Haematology|August 1, 2020
Subcutaneous versus intravenous daratumumab in multiple myelomaMotoharu Shibusawa, Tetsuya Tanimoto
The New England Journal of Medicine|January 3, 2025
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's LymphomaMotoharu Shibusawa, Tetsuya Tanimoto
Preventive Medicine|April 18, 2022
Letter to the editor on the validity of the Mini Mental State Examination and future development of researchMotoi Miura, Tetsuya Tanimoto
Lancet (London, England)|May 2, 2021
Multiple myeloma triplet therapies: baseline characteristics and control groupsMotoharu Shibusawa, Tetsuya Tanimoto
Journal of Cancer Policy|May 13, 2022
Correspondence on a published article in Journal of Cancer PolicyMotoi Miura, Tetsuya Tanimoto
Annals of Internal Medicine|July 15, 2024
Communicating the Value of Influenza Vaccines to PatientsTakeshi Fujieda, Tetsuya Tanimoto
Lancet (London, England)|July 22, 2014
Interventions for people with schizophrenia and their caregivers in IndiaMasako Sugihara, Tetsuya Tanimoto
Pageof 36

Showing results (1-10 of 353) with videos related to

Sort By:
Pageof 36
Drug Design, Development and Therapy|April 8, 2015
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in JapanTetsuya Tanimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2023
Conditioning Regimen in Patients With Adult Acute B Lymphoblastic LeukemiaMotoharu Shibusawa, Tetsuya Tanimoto
JMA Journal|November 23, 2020
Severe Fever with Thrombocytopenia Syndrome: Japan under Threat from Life-threatening Emerging Tick-borne DiseaseAndy Crump, Tetsuya Tanimoto
The Lancet. Haematology|August 1, 2020
Subcutaneous versus intravenous daratumumab in multiple myelomaMotoharu Shibusawa, Tetsuya Tanimoto
The New England Journal of Medicine|January 3, 2025
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's LymphomaMotoharu Shibusawa, Tetsuya Tanimoto
Preventive Medicine|April 18, 2022
Letter to the editor on the validity of the Mini Mental State Examination and future development of researchMotoi Miura, Tetsuya Tanimoto
Lancet (London, England)|May 2, 2021
Multiple myeloma triplet therapies: baseline characteristics and control groupsMotoharu Shibusawa, Tetsuya Tanimoto
Journal of Cancer Policy|May 13, 2022
Correspondence on a published article in Journal of Cancer PolicyMotoi Miura, Tetsuya Tanimoto
Annals of Internal Medicine|July 15, 2024
Communicating the Value of Influenza Vaccines to PatientsTakeshi Fujieda, Tetsuya Tanimoto
Lancet (London, England)|July 22, 2014
Interventions for people with schizophrenia and their caregivers in IndiaMasako Sugihara, Tetsuya Tanimoto
Pageof 36